Evaluation of factors affecting time to achieve dry weight among hemodialysis patients using bioimpedance spectroscopy.


Journal

Irish journal of medical science
ISSN: 1863-4362
Titre abrégé: Ir J Med Sci
Pays: Ireland
ID NLM: 7806864

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 15 01 2018
accepted: 07 04 2018
pubmed: 24 4 2018
medline: 21 3 2019
entrez: 23 4 2018
Statut: ppublish

Résumé

Achieving and maintaining dry weight appears to be an effective strategy for controlling and maintaining normotension among hypertensive patients on hemodialysis (HD). The present study aimed to determine the time at which the majority of patients achieve postdialysis dry weight using bioimpedance spectroscopy (BIS). A total of 220 HD patients were prospectively assessed for fluid overload using the Fresenius body composition monitor (BCM). BCM readings were taken at 30 and 45 min postdialysis. Among the 220 patients included in this study, 120 (54.5%) achieved a euvolemic state at 30 min, and 25 (11.4%) achieved it at 45 min according to the BCM. In the multivariate analysis, vascular access other than arteriovenous fistula (AVF) (OR = 0.286, p value = 0.049) and cardiovascular disease (OR = 0.384, p value = 0.026) had a statistically significant negative association and receiving HD at Hospital Universiti Sains Malaysia (HUSM) (OR = 2.705, p value = 0.008) had a statistically significant positive association with achieving a euvolemic state at 30 min. This suggests that assessing the hydration status at 45 min postdialysis in all patients or in those with identified risk factors for not achieving a euvolemic state at 30 min will provide a relatively accurate assessment for most patients.

Sections du résumé

BACKGROUND BACKGROUND
Achieving and maintaining dry weight appears to be an effective strategy for controlling and maintaining normotension among hypertensive patients on hemodialysis (HD).
OBJECTIVE OBJECTIVE
The present study aimed to determine the time at which the majority of patients achieve postdialysis dry weight using bioimpedance spectroscopy (BIS).
METHODS METHODS
A total of 220 HD patients were prospectively assessed for fluid overload using the Fresenius body composition monitor (BCM). BCM readings were taken at 30 and 45 min postdialysis.
RESULTS RESULTS
Among the 220 patients included in this study, 120 (54.5%) achieved a euvolemic state at 30 min, and 25 (11.4%) achieved it at 45 min according to the BCM. In the multivariate analysis, vascular access other than arteriovenous fistula (AVF) (OR = 0.286, p value = 0.049) and cardiovascular disease (OR = 0.384, p value = 0.026) had a statistically significant negative association and receiving HD at Hospital Universiti Sains Malaysia (HUSM) (OR = 2.705, p value = 0.008) had a statistically significant positive association with achieving a euvolemic state at 30 min.
CONCLUSION CONCLUSIONS
This suggests that assessing the hydration status at 45 min postdialysis in all patients or in those with identified risk factors for not achieving a euvolemic state at 30 min will provide a relatively accurate assessment for most patients.

Identifiants

pubmed: 29680929
doi: 10.1007/s11845-018-1813-2
pii: 10.1007/s11845-018-1813-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

311-319

Références

Kidney Int. 2002 Jun;61(6):2250-8
pubmed: 12028467
Curr Opin Nephrol Hypertens. 2005 Nov;14(6):543-9
pubmed: 16205473
Physiol Meas. 2006 Sep;27(9):921-33
pubmed: 16868355
Nephrol Dial Transplant. 2008 Mar;23(3):808-12
pubmed: 18182405
Contrib Nephrol. 2008;161:115-8
pubmed: 18451666
Nephrol Dial Transplant. 2008 Sep;23(9):2965-71
pubmed: 18458032
Physiol Meas. 2008 May;29(5):639-54
pubmed: 18460765
Am J Nephrol. 2009;29(1):25-30
pubmed: 18663286
Nephrol Dial Transplant. 2009 May;24(5):1574-9
pubmed: 19131355
Hypertension. 2009 Mar;53(3):500-7
pubmed: 19153263
Blood Purif. 2009;27(1):75-80
pubmed: 19169022
Circulation. 2009 Feb 10;119(5):671-9
pubmed: 19171851
Blood Purif. 2009;27(3):235-41
pubmed: 19190396
Nephrol Dial Transplant. 2010 Feb;25(2):538-44
pubmed: 19793930
Tex Heart Inst J. 2009;36(6):510-20
pubmed: 20069075
Perit Dial Int. 2010 Mar-Apr;30(2):208-14
pubmed: 20081049
Clin J Am Soc Nephrol. 2010 Jul;5(7):1255-60
pubmed: 20507951
Hypertension. 2010 Sep;56(3):512-7
pubmed: 20625076
PLoS One. 2011 Feb 24;6(2):e17148
pubmed: 21390320
Acta Physiol Hung. 2011 Jun;98(2):105-16
pubmed: 21616769
Nephrol Dial Transplant. 2012 Jun;27(6):2404-10
pubmed: 22253067
Nephron Clin Pract. 2012;120(3):c173-7
pubmed: 22796734
Nephrol Dial Transplant. 2013 Nov;28(11):2851-9
pubmed: 23828163
Clin J Am Soc Nephrol. 2013 Sep;8(9):1474-5
pubmed: 23949234
Clin J Am Soc Nephrol. 2013 Sep;8(9):1575-82
pubmed: 23949235
BMC Nephrol. 2014 Dec 01;15:189
pubmed: 25435421
PLoS One. 2016 Jul 21;11(7):e0159335
pubmed: 27442587
Clin Kidney J. 2013 Feb;6(1):29-34
pubmed: 27818748

Auteurs

Amjad Khan (A)

Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia. amjadkhan@qau.edu.pk.
Chronic Kidney Disease Resource Centre, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerain, 16150, Kelantan, Malaysia. amjadkhan@qau.edu.pk.
Department of Pharmacy, Quaid-i-Azam University, Islamabad, 45320, Pakistan. amjadkhan@qau.edu.pk.

Amer Hayat Khan (AH)

Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia.
Chronic Kidney Disease Resource Centre, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerain, 16150, Kelantan, Malaysia.

Azreen Syazril Adnan (AS)

Chronic Kidney Disease Resource Centre, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerain, 16150, Kelantan, Malaysia.

Syed Azhar Syed Sulaiman (SAS)

Discipline of Clinical Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, 11800, Penang, Malaysia.

Nafees Ahmad (N)

Faculty of Pharmacy and Health Sciences, University of Balochistan, Quetta, 87300, Pakistan.

Siew Hua Gan (SH)

Human Genome Centre, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, 16150, Kubang Kerian, Kelantan, Malaysia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH